← Leaderboards
Giles Richard Locke
Mayo Clinic Rochester
$2,467,349
Attributed
$2,467,349
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2009–11$2M$1.5M$1M$500K$0
'09
'10
'11
Funding mix
By agency
NIH$2,467,349 · 1
By mechanism
U01$2,467,349 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Tamas Ordog$12,620,237
- Mark D Topazian$1,483,187
- Arthur Beyder$8,889,234
- Yogish C. Kudva$6,907,233
- Matthew Philip Goetz$7,082,692
Others in their field
Top investigators on “Genotype”
- David R. Weir · University Of Michigan At Ann Arbor$303,033,420
- Richard A Gibbs · Baylor College Of Medicine$211,329,145
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Stacey Gabriel · Massachusetts Institute Of Technology$153,486,482
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$141,132,078
Research focus
GenotypeAmericanAmitriptylineGenetic PolymorphismAntidepressive AgentsAnxietyBaseChronicGeneticAffectDisabilityDoseDouble-Blind MethodDrinkingDyspepsiaEscitalopramEvidence BaseExposure ToAnalgesicsAccelerationFunctional DisorderGastric EmptyingGastroenterologyGlutaminase
Grant awards (4)
Antidepressant Therapy for Functional Dyspepsia$499,419
U01 · FY2011 · DK · contact PI
Antidepressant Therapy for Functional Dyspepsia$936,254
U01 · FY2010 · DK · contact PI
Antidepressant Therapy for Functional Dyspepsia$496,120
U01 · FY2010 · DK · contact PI
Antidepressant Therapy for Functional Dyspepsia$535,556
U01 · FY2009 · DK · contact PI